MOS Stock Cash Flow Statements
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Quarterly Cash Flow Statements
Quarterly
|
Annual
Unit: USD | 2011-08-31 | 2011-02-28 | 2010-11-30 | 2010-08-31 | 2010-02-28 | 2009-11-30 | 2009-08-31 | 2009-02-28 | 2008-11-30 | 2008-08-31 | 2008-02-29 | 2007-11-30 | 2007-08-31 | 2007-02-28 | 2006-11-30 | 2006-08-31 | 2005-08-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | |||||||||||||||||
net earnings including noncontrolling interests | 526,400,000 | ||||||||||||||||
adjustments to reconcile net earnings including noncontrolling interests to net cash from operating activities: | |||||||||||||||||
depreciation, depletion and amortization | 120,300,000 | 114,100,000 | 105,700,000 | 104,700,000 | 101,600,000 | 138,900,000 | 92,100,000 | 90,400,000 | 89,400,000 | 87,700,000 | 74,300,000 | ||||||
deferred income taxes | 52,600,000 | 52,200,000 | 36,500,000 | -30,400,000 | 1,100,000 | 23,300,000 | 11,600,000 | -46,700,000 | 149,300,000 | 15,300,000 | 57,600,000 | ||||||
equity in loss (earnings) of nonconsolidated companies, net of dividends | 700,000 | ||||||||||||||||
accretion expense for asset retirement obligations | 7,100,000 | 9,700,000 | 7,200,000 | 7,100,000 | 8,200,000 | 7,100,000 | 7,900,000 | 12,500,000 | 5,700,000 | 8,800,000 | 13,400,000 | ||||||
share-based compensation expense | 13,800,000 | ||||||||||||||||
unrealized loss on derivatives | 17,300,000 | 19,000,000 | |||||||||||||||
other | -500,000 | 15,300,000 | -2,400,000 | 1,700,000 | 700,000 | 2,500,000 | -700,000 | 7,700,000 | 5,600,000 | -1,000,000 | 5,700,000 | 100,000 | 800,000 | 700,000 | -200,000 | 100,000 | -1,700,000 |
changes in assets and liabilities: | |||||||||||||||||
receivables | 130,600,000 | -137,600,000 | -87,600,000 | 41,300,000 | -32,300,000 | -96,500,000 | 111,500,000 | 269,400,000 | 577,600,000 | -521,000,000 | -16,400,000 | ||||||
inventories | -135,800,000 | -314,900,000 | 227,700,000 | -42,300,000 | 15,300,000 | 77,800,000 | 78,900,000 | 176,200,000 | -1,900,000 | -590,200,000 | -21,400,000 | ||||||
other current and noncurrent assets | 1,500,000 | -37,900,000 | 15,500,000 | 61,900,000 | -19,100,000 | ||||||||||||
accounts payable | -34,200,000 | 95,300,000 | 26,500,000 | -27,500,000 | -26,300,000 | 34,800,000 | 77,000,000 | -444,600,000 | -476,200,000 | 273,900,000 | -800,000 | ||||||
accrued liabilities and income taxes | -130,000,000 | 49,700,000 | -68,000,000 | 116,200,000 | |||||||||||||
other noncurrent liabilities | -15,500,000 | -6,700,000 | -47,800,000 | 300,000 | -32,700,000 | 11,100,000 | 9,600,000 | -87,200,000 | 23,100,000 | -80,400,000 | |||||||
net cash from operating activities | 554,300,000 | 365,900,000 | 531,700,000 | 556,200,000 | 476,700,000 | 174,800,000 | 172,400,000 | -11,200,000 | 386,500,000 | 561,500,000 | 528,000,000 | 542,500,000 | 438,400,000 | 147,500,000 | 142,200,000 | 150,600,000 | 81,200,000 |
cash flows from investing activities: | |||||||||||||||||
capital expenditures | -391,400,000 | -311,600,000 | -291,000,000 | -294,700,000 | -208,800,000 | -190,600,000 | -236,200,000 | -196,700,000 | -223,200,000 | -186,900,000 | -86,600,000 | -79,100,000 | -82,100,000 | -61,900,000 | -29,400,000 | -85,200,000 | -90,700,000 |
restricted cash | -1,500,000 | -11,700,000 | 0 | -200,000 | |||||||||||||
investments in nonconsolidated companies | |||||||||||||||||
net cash from investing activities | -392,500,000 | -271,600,000 | 740,000,000 | -681,600,000 | -204,700,000 | -154,600,000 | -236,100,000 | -192,900,000 | 491,400,000 | -187,800,000 | -56,900,000 | -79,100,000 | -73,700,000 | -74,200,000 | -29,600,000 | -85,100,000 | -80,100,000 |
cash flows from financing activities: | |||||||||||||||||
payments of short-term debt | -25,300,000 | -68,600,000 | -134,000,000 | -90,900,000 | -134,000,000 | -57,900,000 | -63,200,000 | -116,700,000 | -51,800,000 | -141,500,000 | -134,200,000 | -185,400,000 | -91,600,000 | -100,500,000 | -181,000,000 | -256,100,000 | |
proceeds from issuance of short-term debt | 15,300,000 | 88,300,000 | 112,600,000 | 83,700,000 | 90,700,000 | 90,800,000 | 77,700,000 | 95,100,000 | 53,400,000 | 118,600,000 | 258,100,000 | 136,800,000 | 106,100,000 | 84,800,000 | 129,000,000 | 231,600,000 | |
payments of long-term debt | -1,800,000 | -459,600,000 | -3,800,000 | -3,700,000 | -3,500,000 | -17,700,000 | -17,400,000 | -3,800,000 | -67,300,000 | -33,800,000 | -158,800,000 | -454,400,000 | -183,100,000 | -1,760,700,000 | -5,400,000 | -6,100,000 | |
proceeds from issuance of long-term debt | 5,300,000 | 16,900,000 | 0 | 0 | 600,000 | 0 | 0 | 100,000 | 1,997,700,000 | 100,000 | 200,000 | ||||||
proceeds from stock options exercised | 1,200,000 | 8,000,000 | 9,200,000 | 1,500,000 | 5,800,000 | 2,800,000 | 2,200,000 | 200,000 | 3,000,000 | 1,100,000 | 11,200,000 | 19,200,000 | 18,400,000 | 14,500,000 | 20,400,000 | 1,500,000 | 23,500,000 |
cash dividends paid | -22,400,000 | -22,400,000 | -22,300,000 | -22,300,000 | -600,900,000 | -22,600,000 | -22,200,000 | -22,200,000 | -22,200,000 | -22,200,000 | -2,600,000 | ||||||
net cash from financing activities | -28,800,000 | -452,400,000 | -30,200,000 | -33,000,000 | -639,000,000 | -5,700,000 | -27,500,000 | -47,700,000 | -83,100,000 | -76,500,000 | 17,100,000 | -485,700,000 | -150,300,000 | 103,600,000 | -36,900,000 | -28,900,000 | -37,300,000 |
effect of exchange rate changes on cash | -1,400,000 | 50,800,000 | 55,200,000 | -1,900,000 | 10,700,000 | 34,900,000 | -13,300,000 | -30,800,000 | -172,900,000 | -68,200,000 | 3,800,000 | 25,300,000 | 4,200,000 | 4,900,000 | -7,500,000 | ||
net change in cash and cash equivalents | 131,600,000 | -307,300,000 | 1,296,700,000 | -160,300,000 | -356,300,000 | 49,400,000 | -104,500,000 | -282,600,000 | 621,900,000 | 229,000,000 | 492,000,000 | 3,000,000 | 218,600,000 | 191,300,000 | 53,600,000 | 41,500,000 | -43,700,000 |
cash and cash equivalents—beginning of period | 3,906,400,000 | 0 | 0 | 2,523,000,000 | 0 | 0 | 2,703,200,000 | 0 | 0 | 1,960,700,000 | 0 | 0 | 420,600,000 | 0 | 0 | 173,300,000 | 245,000,000 |
cash and cash equivalents—end of period | 4,038,000,000 | -307,300,000 | 1,296,700,000 | 2,362,700,000 | -356,300,000 | 49,400,000 | 2,598,700,000 | -282,600,000 | 621,900,000 | 2,189,700,000 | 492,000,000 | 3,000,000 | 639,200,000 | 191,300,000 | 53,600,000 | 214,800,000 | 201,300,000 |
supplemental disclosure of cash flow information: | |||||||||||||||||
cash paid during the period for: | |||||||||||||||||
interest | 13,900,000 | 34,400,000 | -11,200,000 | 32,900,000 | 33,800,000 | -6,800,000 | 39,600,000 | 43,600,000 | 500,000 | 47,400,000 | 55,600,000 | 16,000,000 | 63,400,000 | 85,300,000 | 10,100,000 | 96,100,000 | |
income taxes | 150,100,000 | 128,000,000 | 229,300,000 | 77,200,000 | 118,100,000 | 103,500,000 | 271,000,000 | 155,400,000 | 567,800,000 | 192,700,000 | 104,800,000 | 48,500,000 | 48,500,000 | 19,900,000 | 19,400,000 | 18,000,000 | |
net earnings including non-controlling interests | 542,600,000 | 1,026,800,000 | 298,900,000 | 223,500,000 | 109,000,000 | 102,500,000 | |||||||||||
adjustments to reconcile net earnings including non-controlling interests to net cash from operating activities: | |||||||||||||||||
equity in loss of nonconsolidated companies, net of dividends | |||||||||||||||||
unrealized gain on derivatives | -17,000,000 | -22,300,000 | 15,700,000 | -38,400,000 | |||||||||||||
gain on sale of equity investment | 0 | ||||||||||||||||
excess tax benefit related to stock option exercises | -5,900,000 | -5,500,000 | -700,000 | ||||||||||||||
proceeds from sale of equity investment | 0 | ||||||||||||||||
proceeds from sale of business | 0 | ||||||||||||||||
payment of tender premium on debt | -200,000 | 0 | -5,500,000 | -200,000 | |||||||||||||
equity in (net earnings) loss of nonconsolidated companies, net of dividends | |||||||||||||||||
stock-based compensation expense | 3,000,000 | 13,100,000 | 3,100,000 | 3,200,000 | 14,200,000 | ||||||||||||
purchase of equity investment | 0 | -385,300,000 | |||||||||||||||
dividends paid to non-controlling interests | |||||||||||||||||
cash flows from operating activities | |||||||||||||||||
equity in net earnings of nonconsolidated companies, net of dividends | -3,800,000 | -2,500,000 | -6,000,000 | -29,100,000 | -27,700,000 | -10,200,000 | |||||||||||
cash flows from investing activities | |||||||||||||||||
cash flows from financing activities | |||||||||||||||||
dividend paid to minority shareholder | -100,000 | 0 | -800,000 | -100,000 | -300,000 | -400,000 | -1,400,000 | -1,600,000 | -3,400,000 | -100,000 | |||||||
lower of cost or market write-down | 28,300,000 | ||||||||||||||||
equity in net income (earnings) of nonconsolidated companies, net of dividends | 8,500,000 | ||||||||||||||||
unrealized (gain) loss on derivatives | -19,900,000 | 117,200,000 | |||||||||||||||
proceeds from saskferco note receivable | 0 | ||||||||||||||||
excess tax benefits related to stock option exercises | -3,300,000 | 500,000 | -400,000 | 0 | -2,000,000 | -2,800,000 | |||||||||||
other current assets | 1,700,000 | 8,900,000 | -55,100,000 | -7,300,000 | |||||||||||||
accrued liabilities | -121,500,000 | -299,800,000 | -69,700,000 | -357,700,000 | 138,200,000 | ||||||||||||
net earnings | 58,800,000 | 959,800,000 | 1,184,700,000 | 76,100,000 | |||||||||||||
adjustments to reconcile net earnings to net cash from operating activities: | |||||||||||||||||
minority interest | -700,000 | 1,600,000 | 3,800,000 | 2,200,000 | |||||||||||||
amortization of out-of-market contracts | -3,100,000 | -4,500,000 | |||||||||||||||
amortization of stock-based compensation expense | 3,600,000 | 3,800,000 | 10,100,000 | ||||||||||||||
gain on sale of equity method investment | 0 | ||||||||||||||||
proceeds from sale of equity method investment | 0 | ||||||||||||||||
proceeds from sale of businesses | 400,000 | -300,000 | 7,800,000 | ||||||||||||||
payments of restricted cash | 3,700,000 | -31,100,000 | -1,200,000 | ||||||||||||||
contributions from cargill, incorporated | 2,200,000 | ||||||||||||||||
restructuring and other charges | |||||||||||||||||
proceeds from sale of investment | |||||||||||||||||
payments for deferred financing costs | |||||||||||||||||
payment for swap termination | |||||||||||||||||
cash acquired in acquisition of imc global inc. | |||||||||||||||||
proceeds from (investment in) note of saskferco products, inc. | |||||||||||||||||
investment in nonconsolidated companies | |||||||||||||||||
contributions by cargill, inc. | |||||||||||||||||
changes in short-term and long-term debt due to cargill, inc and affiliates | |||||||||||||||||
increase in debt refinancing and issuance costs | |||||||||||||||||
increase in equity in nonconsolidated companies, net of dividends | |||||||||||||||||
changes in assets and liabilities, exclusive of acquisition: | |||||||||||||||||
acquisition of imc global inc., net of cash acquired | |||||||||||||||||
investment in note of saskferco products inc. | |||||||||||||||||
investments in businesses acquired and minority interests | |||||||||||||||||
changes in short-term debt | |||||||||||||||||
stock options exercised and restricted stock awards | |||||||||||||||||
increase in restricted cash | |||||||||||||||||
cash dividends paid to cargill, incorporated | |||||||||||||||||
cash and cash equivalents—beginning of year | |||||||||||||||||
non cash investing activities: | |||||||||||||||||
issuance of mosaic common stock, preferred stock and stock options in exchange for imc common stock, preferred stock and stock options | |||||||||||||||||
non cash financing activities: | |||||||||||||||||
contributions from cargill, incorporated to convert short and long-term debt to common stock and capital in excess of par value |